Correlation Between Mineralys Therapeutics, and MDxHealth

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and MDxHealth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and MDxHealth into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and MDxHealth SA ADR, you can compare the effects of market volatilities on Mineralys Therapeutics, and MDxHealth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of MDxHealth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and MDxHealth.

Diversification Opportunities for Mineralys Therapeutics, and MDxHealth

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Mineralys and MDxHealth is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and MDxHealth SA ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MDxHealth SA ADR and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with MDxHealth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MDxHealth SA ADR has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and MDxHealth go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and MDxHealth

Given the investment horizon of 90 days Mineralys Therapeutics, is expected to generate 150.66 times less return on investment than MDxHealth. But when comparing it to its historical volatility, Mineralys Therapeutics, Common is 17.29 times less risky than MDxHealth. It trades about 0.01 of its potential returns per unit of risk. MDxHealth SA ADR is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  691.00  in MDxHealth SA ADR on August 24, 2024 and sell it today you would lose (503.00) from holding MDxHealth SA ADR or give up 72.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy91.35%
ValuesDaily Returns

Mineralys Therapeutics, Common  vs.  MDxHealth SA ADR

 Performance 
       Timeline  
Mineralys Therapeutics, 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Mineralys Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in December 2024.
MDxHealth SA ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MDxHealth SA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Mineralys Therapeutics, and MDxHealth Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mineralys Therapeutics, and MDxHealth

The main advantage of trading using opposite Mineralys Therapeutics, and MDxHealth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, MDxHealth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MDxHealth will offset losses from the drop in MDxHealth's long position.
The idea behind Mineralys Therapeutics, Common and MDxHealth SA ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios